251 related articles for article (PubMed ID: 1342969)
21. Topographical dissociation of BCL-2 messenger RNA and protein expression in human lymphoid tissues.
Chleq-Deschamps CM; LeBrun DP; Huie P; Besnier DP; Warnke RA; Sibley RK; Cleary ML
Blood; 1993 Jan; 81(2):293-8. PubMed ID: 8422456
[TBL] [Abstract][Full Text] [Related]
22. [Cytogenetic and molecular aspects in MALT lymphomas].
Robledo M; Santos M; Santón A; Echezarreta G; Rivas C; Benítez J
Sangre (Barc); 1991 Aug; 36(4):295-9. PubMed ID: 1776108
[TBL] [Abstract][Full Text] [Related]
23. Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma.
Butler MP; Iida S; Capello D; Rossi D; Rao PH; Nallasivam P; Louie DC; Chaganti S; Au T; Gascoyne RD; Gaidano G; Chaganti RS; Dalla-Favera R
Cancer Res; 2002 Jul; 62(14):4089-94. PubMed ID: 12124346
[TBL] [Abstract][Full Text] [Related]
24. Molecular features of a new human lymphoma cell line carrying both BCL2 and BCL6 gene rearrangements.
Yonetani N; Akasaka T; Akasaka H; Ohno H; Okuma M; Miura I; Takahashi N; Miyanishi S; Okumura A; Muramatsu M; Fukuhara S
Oncogene; 1998 Aug; 17(8):971-9. PubMed ID: 9747876
[TBL] [Abstract][Full Text] [Related]
25. Establishment of a human herpes virus-8-negative malignant effusion lymphoma cell line (STR-428) carrying concurrent translocations of BCL2 and c-MYC genes.
Taira T; Nagasaki A; Tomoyose T; Miyagi J; Kakazu N; Makino S; Shinjyo T; Taira N; Masuda M; Takasu N
Leuk Res; 2007 Sep; 31(9):1285-92. PubMed ID: 17368758
[TBL] [Abstract][Full Text] [Related]
26. Pseudonegative BCL2 protein expression in a t(14;18) translocation positive lymphoma cell line: a need for an alternative BCL2 antibody.
Masir N; Campbell LJ; Jones M; Mason DY
Pathology; 2010 Apr; 42(3):212-6. PubMed ID: 20350212
[TBL] [Abstract][Full Text] [Related]
27. Derivative (3)t(3;18)(q27;q21)t(18;16)(q21;?) involving the BCL2 and BCL6 genes in follicular lymphoma with t(3;14;18)(q27;q32;q21).
Yamamoto K; Ono K; Katayama Y; Shimoyama M; Matsui T
Cancer Genet Cytogenet; 2007 Nov; 179(1):69-75. PubMed ID: 17981218
[TBL] [Abstract][Full Text] [Related]
28. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
[TBL] [Abstract][Full Text] [Related]
29. Translocations t(14;18) and t(8;14) with rearranged bcl-2 and c-myc in a case presenting as B-ALL (L3).
Brito-Babapulle V; Crawford A; Khokhar T; Laffan M; Matutes E; Fairhead S; Catovsky D
Leukemia; 1991 Jan; 5(1):83-7. PubMed ID: 1999960
[TBL] [Abstract][Full Text] [Related]
30. Gene amplification of Japanese non-Hodgkin lymphoma with involvement of the BCL2 gene.
Miyamura K; Kobayashi T; Sasaki T; Ibuka T; Imai K; Sakai Y; Kawaguchi K; Miyashita T; Iwaya M; Mizutani S
Int J Hematol; 1991 Apr; 54(2):137-40. PubMed ID: 1747446
[TBL] [Abstract][Full Text] [Related]
31. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
Capaccioli S; Quattrone A; Schiavone N; Calastretti A; Copreni E; Bevilacqua A; Canti G; Gong L; Morelli S; Nicolin A
Oncogene; 1996 Jul; 13(1):105-15. PubMed ID: 8700536
[TBL] [Abstract][Full Text] [Related]
32. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.
Strasser A; Harris AW; Bath ML; Cory S
Nature; 1990 Nov; 348(6299):331-3. PubMed ID: 2250704
[TBL] [Abstract][Full Text] [Related]
33. Hodgkin cells accumulate mRNA for bcl-2.
Hell K; Lorenzen J; Fischer R; Hansmann ML
Lab Invest; 1995 Oct; 73(4):492-6. PubMed ID: 7474920
[TBL] [Abstract][Full Text] [Related]
34. Concurrent translocation of BCL2 and MYC with a single immunoglobulin locus in high-grade B-cell lymphomas.
Knezevich S; Ludkovski O; Salski C; Lestou V; Chhanabhai M; Lam W; Klasa R; Connors JM; Dyer MJ; Gascoyne RD; Horsman DE
Leukemia; 2005 Apr; 19(4):659-63. PubMed ID: 15716988
[TBL] [Abstract][Full Text] [Related]
35. Variation in BCL2 protein expression in follicular lymphomas without t(14;18) chromosomal translocations.
Masir N; Jones M; Abdul-Rahman F; Florence CS; Mason DY
Pathology; 2012 Apr; 44(3):228-33. PubMed ID: 22406486
[TBL] [Abstract][Full Text] [Related]
36. Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma.
Lee JT; Innes DJ; Williams ME
J Clin Invest; 1989 Nov; 84(5):1454-9. PubMed ID: 2509518
[TBL] [Abstract][Full Text] [Related]
37. Genomic organization of the translocations (8;14) and (14;18) in a new lymphoma cell line.
Lambrechts AC; Dorssers LC; Hupkes PE; van Gurp R; Baumgarten R; Hagemeijer A; van 't Veer MB; Touw IP
Leukemia; 1994 Jul; 8(7):1164-71. PubMed ID: 8035608
[TBL] [Abstract][Full Text] [Related]
38. Cytogenetic, molecular biological and clinical study of B-cell lymphomas with 14;18 translocation in Japanese patients.
Takechi M; Tanaka K; Hashimoto T; Asaoku H; Dohy H; Kikuchi M; Kamada N
Leukemia; 1991 Dec; 5(12):1069-75. PubMed ID: 1774956
[TBL] [Abstract][Full Text] [Related]
39. Oncogene rearrangement in non-Hodgkin's lymphoma with a 14q+ chromosome of unknown origin.
Nakamine H; Masih AS; Chan WC; Sanger WG; Armitage JO; Weisenburger DD
Leuk Lymphoma; 1993 May; 10(1-2):79-88. PubMed ID: 8374527
[TBL] [Abstract][Full Text] [Related]
40. Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin's lymphomas.
Tanaka S; Louie DC; Kant JA; Reed JC
Blood; 1992 Jan; 79(1):229-37. PubMed ID: 1339299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
